Introduction
The occurrence of Helicobacter pylori as an aetiological factor in the development of gastroduodenal ulcers 1,2 and gastric cancer 3 is now well established. Approximately half of the world's population is thought to be infected with H. pylori. 1 Current effective triple therapy for the eradication of H. pylori includes metronidazole. Failure of treatment regimes involving metronidazole has been attributed to the possession of pre-treatment metronidazole-resistant strains [4] [5] [6] or to the development of metronidazole-resistant phenotypes during treatment. 4, 5, 7 Previous use of metronidazole and the occurrence of metronidazole-resistant H. pylori in the community appear to be related. The widespread use of metronidazole in the treatment of anaerobic infections, such as amoebiasis and giardiasis, in hot developing countries is thought to account for the high prevalence of metronidazole-resistant H. pylori in these countries. 8 In a similar way, the slightly higher prevalence of metronidazole-resistant strains in women than in men in developed countries may be attributed to the use of metronidazole in the treatment of gynaecological infections. 5, 8 With metronidazole resistance on the increase in the H. pylori population, the effectiveness of current tripletherapy regimes containing metronidazole may be compromised. A number of advances to understanding this phenomenon have been achieved in recent years. Resistance to metronidazole is lost on exposure to an anaerobic environment, the degree of sensitivity presented being dependent upon the time of exposure. 9, 10 We have shown that the increase in sensitivity upon exposure to anaerobic conditions is due to an increase in the rate of uptake and reduction of the drug. 11 In addition, we have found metronidazole-resistant H. pylori to be resistant to other 5-nitroimidazole drugs and that, like with metronidazole, this resistance is lost under anaerobiosis.
In order to understand the mechanism of metronidazole 
Cultures
Frozen cultures were inoculated on to Columbia agar containing 5% oxalated horse blood and DENT H. pylori selective supplement (Oxoid, Unipath, Basingstoke, UK) and incubated for 3 days under microaerophilic conditions. Colonies were suspended in 7 mL of TSB containing 5% horse serum (culture broth) and left static for 3 days under microaerophilic conditions; this was used to inoculate larger fresh culture broth. Cultures were left static under microaerophilic conditions for 4 days before being shaken overnight at 60 rpm.
Selection of mutants conferring resistance to metronidazole
Helicobacter pylori cultures left static under microaerophilic conditions for 3 days were diluted 100-fold in TSB and 100 L was spread on to TSA plates containing 7% horse blood and a gradient of metronidazole. The gradient plates were incubated under microaerophilic conditions for 3 days. Colonies f o r m e d on the highest concentration were resuspended in culture broth. The MIC after each successive passage was determined by the agar dilution method on TSA plates containing 7% horse blood.
Restriction fragment length polymorphism analysis
Five-day-old H. pylori growth was harvested from blood agar plates and resuspended in TE buffer (10 mM Tris, 1 mM EDTA). DNA was extracted using a modified CTAB (hexadecyltrimethylammonium bromide) method of Doyle & Doyle 12 ; by first incubating the cells for 1 h at 40°C with 0.5 mg/mL Proteinase K (Sigma, Poole, UK) and 10% SDS. Five micrograms of DNA was digested overnight with 10 units of HindIII restriction endonuclease according to the manufacturer's instructions (Promega, Southampton, UK), loaded into a 0.8% agarose gel in TBE buffer (89 mM Tris, 89 mM boric acid, 2 mM EDTA) and electrophoresed at 7 V/cm.
Effect of bacterial cell density on metronidazole activity
Serial 10-fold dilutions of broth cultures of H. pylori at a bacterial cell density of 10 8 cfu/mL were prepared in 20 mL TSB in 100 mL conical flasks. The TSB was equilibrated with a microaerophilic atmosphere overnight before use. Metronidazole was added to a final concentration of 10 mg/L and the cultures were left static under microaerophilic conditions. Colony counts were performed by diluting the culture in 10-fold steps in TSB and dropping 20 L on to TSA plates containing 7% horse blood. The plates were incubated under microaerophilic conditions for 3 days.
Crude bacterial extract
Bacterial cells were harvested by centrifuging 75 mL of broth cultures at 4000g for 30 min, discarding the supernatant and washing the pellet once with 50 mM potassium phosphate buffer pH 7.8. The pellet was reconstituted in 5 mL of buffer and sonicated at 20,000 cps for 2 min on ice. Membrane fractions and whole cells were removed by centrifugation at 50,000g for 40 min and the supernatant was assayed for enzyme activity before being stored at -20°C.
NAD(P)H oxidase assay
NAD(P)H oxidase activity in crude bacterial supernant was assayed in phosphate buffer containing 0.1 mM -NAD(P)H and 0.2-0.5 mg of protein by measuring the decrease in absorbance of NAD(P)H at 340 nm. 13 For the determination of NAD(P)H oxidase activity under anaerobic conditions, oxygen-free nitrogen gas was bubbled through the assay mixture in Thunberg cuvettes for 20 min, the cuvettes were sealed and the absorbance decrease was recorded. Enzyme activity was calculated using the molar extinction coefficient of NAD(P)H at 340 nm of 6.22 1 0 3 /mol/cm. The concentration of soluble protein was determined by the method of Lowry et al. 1 4 , with bovine serum as the standard.
Statistical analysis
Statistical analysis was performed using the MannWhitney test.
Results

Selection of mutants conferring resistance to metronidazole
Mutants conferring resistance to metronidazole were selected from strains of H. pylori metronidazole-sensitive (Mtz S ) wild types. The MIC of the mutants did not change even after subculturing on antibiotic-free media at least three times, thus these mutants were stable for metronidazole resistance. Genomic analysis of H. pylori has shown considerable genomic diversity in this species. 15, 16 Each wild type strain of H. pylori possessed a unique DNA restriction pattern when digested with HindIII and each metronidazole-resistant (Mtz R ) mutant possessed the same restriction pattern as its parent strain (Figure 1 ), confirming that the mutants were derived from the wild types.
Effect of bacterial cell density on metronidazole activity
The effective activation of metronidazole by H. pylori cultures, at various bacterial cell densities, was assessed by diluting high density cultures in 10-fold steps and adding metronidazole to a final concentration of 10 mg/L. Mtz cultures log 2.0 and 5 10 6 cfu/mL cultures log 1.0. Therefore, the amount of cell kill in Mtz R cultures of a cell density of >10 6 cfu/mL was related to the initial density of the culture. No loss in viability occurred in Mtz R cultures of an initial cell density of <1 10 6 cfu/mL. The wild-type strain NCTC 11637, which was resistant to metronidazole, also displayed this apparent lack of loss in viability in cultures with a bacterial cell density of <1 10 6 cfu/mL. Bacterial cultures of a high cell density possess a lower dissolved oxygen content and a lower redox potential compared with cultures of a lower cell density. Metronidazole has a very low reduction potential (E 1 7 -486 mV) and would only be activated in conditions in which a low redox status is maintained. It can be reasoned that the loss of viability in Mtz R cultures of a high cell density is due to the creation of an environment of a suitably low redox status and low oxygen tension, which allows the reduction of metronidazole to occur. As the cultures lose viability so a decrease in the utilization of oxygen occurs and the dissolved oxygen content of the environment increases, creating an environment unfavourable for metronidazole reduction. In cultures diluted to a bacterial cell density of <10 6 cfu/mL the dissolved oxygen content of the environment is such that no significant drug reduction occurs, hence the retention of viability in these cultures. In highdensity Mtz R cultures resistance is temporarily compromised due to the low oxygen content. The ability of low-density Mtz S cultures to activate metronidazole and lose viability may be due to an ability to maintain a low intracellular redox potential despite the extracellular oxygen concentration. This may be due to a system which is able to remove dissolved oxygen from the intracellular environment.
NAD(P)H oxidase activity in crude bacterial extracts
Some aerobic and anaerobic bacteria are known to possess soluble NAD(P)H oxidases which are able to remove oxygen from the environment. 17, 18 Crude bacterial supernatants of H. pylori were found to possess measurable NADH and NADPH oxidase activity. Under anaerobic conditions almost no loss of NADH and NADPH occurred, indicating that oxygen was required for the loss of NADH and NADPH from the assay system. Mtz R mutants contained approximately a third of the NADH oxidase activity found in the Mtz S wild types (Table) . This difference was found to be significant ( 0.01). Mtz R wild types (NCTC 11637 and T 5410) contained a low level of NADH oxidase activity similar to that displayed in the Mtz R mutants. The level of NADPH oxidase activity was nearly always over twice as high as the level of NADH oxidase. Overall, NADPH was slightly higher in Mtz S wild types than in their respective Mtz R mutants, though statistically no significant difference between the levels in sensitive and resistant strains was apparent ( 0.01). In addition, Mtz R mutants often contained the same level of NADPH oxidase as their Mtz S wild-type parent strains and the Mtz R wild types contained a NADPH oxidase level on par with that found in the Mtz S wild types. This was not the case with the NADH oxidase activity which was always considerably greater in the Mtz S wild types than in their respective Mtz R mutants.
Discussion
Metronidazole is regarded as the drug of choice for anaerobes and as such would not be expected to be effective in the presence of oxygen. The fact that it is an essential component of current triple-therapy regimes suggests either that H. pylori exists in an anaerobic or hypoxic environment in gastric pits, or that the organism is capable of scavenging oxygen, creating an environment suitable for the reduction of the drug. This report shows that a relationship exists between the intracellular oxygen-scavenging ability of H. pylori and the sensitivity of the bacterium to metronidazole. Mtz R strains of H. pylori possessed considerably lower soluble cytosolic NADH oxidase activity than Mtz S strains. Soluble cytosolic NAD(P)H oxidase enzymes have been purified from anaerobic and aerobic bacteria. [19] [20] [21] [22] [23] These enzymes are able to reduce oxygen directly to hydrogen peroxide or water. The function of these enzymes in vivo is not known though it is thought that they may be involved in scavenging oxygen from the intracellular environment or in the regeneration of NAD . 13, 17, 18, 24 Nitroimidazoles are activated by reduction of the nitro group attached to the imidazole ring. 25 Metronidazole and other 5-nitroimidazole drugs possess low reduction potentials and are unable to be activated to a clinically significant extent by aerobic organisms. This makes the 5-nitroimidazoles selectively toxic towards anaerobic organisms which are able to attain the low intracellular redox environment required for drug activation. H. pylori and other microaerophilic bacteria contain elements of both aerobic and anaerobic metabolism [26] [27] [28] [29] [30] and are sensitive to metronidazole and other 5-nitroheterocyclic drugs. 10, 31 In anaerobes metronidazole reduction is mediated via the electron carrier protein ferredoxin, which is a component of the oxygen-sensitive pyruvate:ferredoxin oxidoreductase (PFOR) complex. The PFOR is part of a unique pathway in which pyruvate is decarboxylated to acetate or acetylcoenzyme A and carbon dioxide. A pyruvate: flavodoxin oxidoreductase (PFlOR) has recently been discovered in H. pylori and shown to cause the reduction of metronidazole. 32 Anaerobic resistance to metronidazole in the protozoan Trichomonas vaginalis and the bacterium Bacteroides fragilis has been reported to be due to a decrease in PFOR activity. [33] [34] [35] In B. fragilis this is due to a decreased transcription of the ferredoxin gene. 35 If metronidazole resistance in H. pylori is due to a decrease in PFlOR activity, it is feasible that PFlOR activity may be restored upon exposure to anaerobic conditions, causing the reduction of metronidazole, thus accounting for the increased sensitivity to drug when exposed to anaerobic conditions. Likewise, the killing of Mtz R cultures that occurs at a high bacterial cell density could be accounted for by a conver- sion in the metabolism to primarily anaerobic metabolic pathways in cultures as they grow and outstrip the supply of oxygen. In such a scenario, as the culture loses viability upon exposure to metronidazole so the oxygen tension of the environment may be increased and anaerobic metabolism involving PFlOR activity is switched off; metronidazole would no longer be activated and no more killing would occur. All this is a reasonable explanation but does not explain the phenomenon that when a Mtz R culture of high bacterial cell density is diluted over a thousand-fold no kill occurs. Logically, the diluted cultures would be expected to possess the same level of PFlOR activity, relative to the number of bacteria cells present, as the original high density culture and therefore the same proportional kill of the population would be expected. This did not occur when the population was diluted below a cell density of 10 6 cfu/mL. It is probable that Mtz S and Mtz R strains do contain PFlOR activity though it is hard to see how a mechanism based on the loss of PFlOR could explain fully these results. In addition, Daucher & Krieg could find no relationship between the level of PFOR activity in microaerophilic Campylobacter species, to which H. pylori is closely related, and resistance to metronidazole. 36 Oxygen has a very high affinity for electrons (E 1 7 -150 mV) and would be able to outcompete 5-nitroimidazole drugs for abstraction of electrons from reduced flavodoxin or be able to abstract the electron from the nitro group of the reduced drug, thereby reforming the inactive parent compound (a futile cycling mechanism). In metronidazolesensitive strains NADH oxidase activity may be able to maintain a sufficiently low oxygen concentration at the site of metronidazole activation to allow reduction to occur. In resistant strains the presence of a higher intracellular oxygen concentration may prevent the proper functioning of the PFlOR complex or the oxygen may be reduced to superoxide by the flavoprotein component of the PFlOR, thereby preventing electron flow to metronidazole ( Figure  3 ). This mechanism displays characteristics of the aerobic type of metronidazole resistance found in T. vaginalis. Here resistance to metronidazole occurs as the oxygen concentration of the environment is increased 37 and is thought to be due to the hydrogenosomal NAD(P)H oxidases having an apparent lower affinity for oxygen than those in sensitive strains. 38 We speculate that NADH oxidase activity in H. pylori may be somehow closely linked to the PFlOR complex so as to allow proper functioning of the complex in a low oxygen environment.
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NADH oxidases purified from aerobic bacteria are also able to use NADPH as an electron donor 20, 22 and the enzyme or enzymes possessing the NADH oxidase activity in H. pylori may have an affinity for NADPH as a substrate also. Since statistically the level of NADPH oxidase activity was no different in sensitive and resistant strains, the NADPH oxidase activity in H. pylori may not play a role in maintaining an environment suitable for the activation of metronidazole.
Triple therapy with metronidazole as a component has a success rate of >90%. 39 Resistance to metronidazole is a problem, but resistance does not procure failure of the treatment regime. Approximately a third of patients harbouring metronidazole-resistant strains of H. pylori before treatment are subsequently cured of the bacterium after a 1-week course of triple therapy with metronidazole as one of the components. 6 This success could be attributed solely to the action of bismuth and the other antibiotic present; however, the apparent effectiveness of this treatment may also be due to short periods of anaerobiosis occurring at the site of infection, which would cause metronidazole to be activated in the resistant population. If the treatment is extended from 1 week to 2 weeks then the chances of eradicating the metronidazole-resistant H. pylori population is increased to around 60-70%. [4] [5] [6] Increasing the duration of treatment may increase the likelihood of anaerobiosis occurring during the treatment period and may account for the increased success rate.
Metronidazole-resistant phenotypes exist in microaerophilic Campylobacter species. The scavenging of oxygen from the intracellular environment may account for the sensitivity of microaerophilic Camp y l o b a c t e r species, and other microaerophilic bacteria, to metronidazole and its loss 351 to the development of resistance. Further studies into the nature of this phenomenon will increase our understanding of metronidazole resistance in H. pylori and may be applicable to other microaerophilic bacteria. In the following reaction, sensitivity or resistance to metronidazole depends upon the absence or presence of oxygen at the site of metronidazole reduction. S denotes a pathway involved in sensitivity and R a resistance pathway. In sensitive strains, NADH oxidase removes molecular oxygen from the site of metronidazole reduction (S1), hence metronidazole is reduced by flavodoxin (S2). The reduced drug causes DNA damage (S3) which leads to cell death (S4). In resistant strains, oxygen outcompetes metronidazole for the electrons from the flavodoxin and consequently no metronidazole activation occurs (R1) or metronidazole is reduced by the flavodoxin (R2) but is subsequently oxidized back to the inactive parent compound by a futile cycling mechanism (R3).
